ResearcherThe Netherlands Cancer InstituteNo recent work listed

Michael Hauptmann

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8539-0148; OpenAlex author ID A5041206659. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2016: 1 paper

Papers 1

Increased pancreatic cancer risk following radiotherapy for testicular cancer. Co-author DOI 10.1038/bjc.2016.272 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Charles F. Lynch · 1 shared paper, 2016 · strength 0.04
- Paper Increased pancreatic cancer risk following radiotherapy for testicular cancer. DOI 10.1038/bjc.2016.272 ↗
Ethel S. Gilbert · 1 shared paper, 2016 · strength 0.04
- Paper Increased pancreatic cancer risk following radiotherapy for testicular cancer. DOI 10.1038/bjc.2016.272 ↗
Lindsay Morton · 1 shared paper, 2016 · strength 0.04
- Paper Increased pancreatic cancer risk following radiotherapy for testicular cancer. DOI 10.1038/bjc.2016.272 ↗
Graça M. Dores · 1 shared paper, 2016 · strength 0.04
- Paper Increased pancreatic cancer risk following radiotherapy for testicular cancer. DOI 10.1038/bjc.2016.272 ↗
Lois B. Travis · 1 shared paper, 2016 · strength 0.04
- Paper Increased pancreatic cancer risk following radiotherapy for testicular cancer. DOI 10.1038/bjc.2016.272 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.